<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">patmedfar</journal-id><journal-title-group><journal-title xml:lang="en">Patient-Oriented Medicine and Pharmacy</journal-title><trans-title-group xml:lang="ru"><trans-title>Пациентоориентированная медицина и фармация</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-1924</issn><publisher><publisher-name>LLC Izdatelstvo OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2949-1924-0111</article-id><article-id custom-type="edn" pub-id-type="custom">JBWPRC</article-id><article-id custom-type="elpub" pub-id-type="custom">patmedfar-197</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INTERNAL MEDICINE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВНУТРЕННИЕ БОЛЕЗНИ</subject></subj-group></article-categories><title-group><article-title>Role of induced blood oxidation parameters in the pathogenesis of complications during myocardial revascularization</article-title><trans-title-group xml:lang="ru"><trans-title>Значение показателей индуцированного окисления крови в патогенезе развития осложнений при реваскуляризации миокарда</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5362-8702</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шерешнева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shereshneva</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шерешнева Марина Владимировна - ассистент кафедры терапии им. профессора Е. Н. Дормидонтова</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Marina V. Shereshneva - Assistant, Department of Therapy named after professor E. N. Dormidontov</p><p>Yaroslavl</p></bio><email xlink:type="simple">m.shereshneva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0032-0341</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлов</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хохлов Александр Леонидович - д. м. н., профессор, академик РАН, зав. кафедрой фармакологии и клинической фармакологии, ректор</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Alexander L. Khokhlov - Dr. Sci. (Med.), professor, Academician of the Russian Academy of Sciences, Head of the Department of Pharmacology and Clinical Pharmacology, Rector</p><p>Yaroslavl</p></bio><email xlink:type="simple">rector@ysmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ярославский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2025</year></pub-date><volume>3</volume><issue>4</issue><fpage>5</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Shereshneva V.V., Khokhlov A.L., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Шерешнева М.В., Хохлов А.Л.</copyright-holder><copyright-holder xml:lang="en">Shereshneva V.V., Khokhlov A.L.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pomph.ru/jour/article/view/197">https://www.pomph.ru/jour/article/view/197</self-uri><abstract><p>Background. Despite its proven positive impact on prognosis and quality of life, coronary artery disease (CAD) surgical treatment is accompanied by the development of ischemia-reperfusion injury, a phenomenon underpinned by oxidative stress that mediates the development of the most common postoperative complications.Materials and methods. The study group consisted of 89 patients with CAD, including 64 patients who underwent coronary artery bypass grafting. The control group consisted of 24 healthy volunteers. Blood oxidation parameters were assessed using a YSI 5300 biological oxygen monitor (Yellow Springs Instrument Co., Inc., USA).Results. In patients with CAD, compared with the control group, higher values of Vox (2.07 &gt; 1.9; p = 0.049), Vinit (3.29 &gt; 2.11; p = 0.0001), Vmax (3.5 &gt; 2.54; p = 0.001), coefficient of oxidative activity (KA) (40.0 &gt; 5.89, p = 0.0001), and a shorter initiation period (T) (0.97 &lt; 1.91; p = 0.001) were observed. In the comparative aspect, statistically significant differences in the indices of induced blood oxidation depending on the type of cardiac surgery were not observed either 10 days (B2) or 6 months after the operation (B3). In the group of patients who had previously suffered a myocardial infarction, the Vox values were statistically significantly higher in the event of a fatal outcome (2.3 (2.3; 2.5) and 1.9 (1.7; 2.3), respectively (p = 0.04). The results of the logistic regression analysis demonstrated a statistically significant effect of the Vox value on the development of cardiac arrhythmias (p = 0.0001) and cognitive dysfunction (p = 0.004) in the postoperative period.Conclusions. Patients with CAD had higher blood oxidation parameters. The choice of revascularization technique (cardiopulmonary bypass or off-pump surgery) did not affect these parameters. However, monitoring these parameters during perioperative patient care appears to be useful for predicting the development of complications such as cardiac arrhythmias and postoperative cognitive dysfunction.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Хирургическое лечение ишемической болезни сердца (ИБС), несмотря на доказанное положительное влияние на прогноз и качество жизни пациентов, сопровождается развитием феномена-ишемии реперфузии, в основе которого лежит окислительный стресс, опосредующий развитие наиболее распространённых послеоперационных осложнений.Материалы и методы. Группа наблюдения представлена 89 больными стабильной ИБС, в т. ч. 64 пациента, которым было выполнено шунтирование коронарных артерий, группу контроля составили 24 здоровых добровольца. Оценка показателей индуцированного окисления крови проводилась на биологическом кислородном мониторе YSI 5300 (Yellow Springs Instrument Company, YSI Inc., США).Результаты. У пациентов со стабильной ИБС по сравнению с группой контроля наблюдались более высокие показатели Vox (2,07&gt;1,9; p=0,049), Vinit (3,29&gt;2,11; р=0,0001), Vmax (3,5&gt;2,54; p=0,001), коэффициента окислительной активности КА (40,0&gt;5,89, p=0,0001), более короткий период инициации T (0,97&lt;1,91; p=0,001). В сравнительном аспекте статистически значимых различий показателей индуцированного окисления крови в зависимости от вида кардиохирургического вмешательства не наблюдалось как через 10 суток (В2), так и через 6 месяцев после операции (В3). В группе больных, ранее перенёсших инфаркт миокарда, значения Vox были статистически значимо выше в случае наступления летального исхода (2,3 (2,3; 2,5) и 1,9 (1,7; 2,3) соответственно, р=0,04). Результаты логистического регрессионного анализа продемонстрировали статистически значимое влияние значений Vox на развитие нарушений ритма сердца (p=0,0001) и когнитивной дисфункции (р=0,004) в послеоперационном периоде.Выводы. Пациенты с ИБС демонстрируют более высокие значения показателей индуцированного окисления крови. Выбор методики реваскуляризации (в условиях искусственного кровообращения или на работающем сердце) не оказывает влияния на эти показатели, однако их мониторинг в рамках периоперационного ведения больных, как представляется, может использоваться с целью прогнозирования развития таких осложнений, как нарушения ритма и послеоперационная когнитивная дисфункция.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>окислительный стресс</kwd><kwd>коронарное шунтирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary artery disease</kwd><kwd>oxidative stress</kwd><kwd>coronary artery bypass grafting</kwd></kwd-group></article-meta></front><body><p>Introduction</p><p>Diseases of the circulatory system, with a observed steady upward trend in the number of cases, remain the leading cause of mortality in developed countries [<xref ref-type="bibr" rid="cit1">1</xref>]. In the Russian Federation, about one-third of all deaths among individuals over the age of 35 are attributed to coronary artery disease (CAD) [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>The pathogenesis of CAD, a condition characterized by an imbalance between myocardial oxygen demand and adequate blood supply, is fundamentally linked to atherosclerotic lesions of the coronary arteries. Atherogenesis, as a typical pathological process, is closely associated with the phenomenon of oxidative stress — an imbalance between the release of reactive oxygen species (ROS) and the activity of neutralizing antioxidant defense mechanisms [<xref ref-type="bibr" rid="cit3">3</xref>]. Despite the possibilities of conservative therapy, in some cases myocardial revascularization is an irreplaceable treatment method for CAD patients, capable of improving both prognosis and quality of life. Surgical treatment of CAD is inevitably accompanied by reperfusion injury, an inflammatory response, and intensified ROS production, collectively contributing to the development of postoperative complications [4, 5].</p><p>Adequate assessment of the oxidative status of a macroorganism is a complex task due to the impossibility of direct quantitative measurement of reactive particles in vivo because of their instability, the multitude of interconnections between components of systems responsible for homeostasis, and their dynamic changes. Consequently, in most studies addressing the issue of oxidative stress, the assessment of oxidative balance is carried out using indirect methods [<xref ref-type="bibr" rid="cit6">6</xref>].</p><p>Investigating parameters of induced blood oxidation does not allow for the quantitative measurement of oxidant or antioxidant content. However, it reflects the interaction of a large number of factors influencing free radical oxidation over time, which, it appears, allows for "modeling oxidative stress" and thereby getting closer to in vivo conditions.</p><p>Thus, studying induced blood oxidation parameters and their relationship with clinical and laboratory parameters, as well as the revascularization technique, appears to be a promising task. Solving it could personalize the approach to managing CAD patients and predicting possible complications after revascularization.</p><p>Materials and methods</p><p>The study group consisted of 89 patients with stable coronary artery disease, including 64 patients with a history of myocardial infarction (the PMI group). The control group comprised 24 healthy volunteers, comparable in age and sex to the study group. Coronary artery bypass grafting was performed on 64 patients; indications for revascularization were determined in accordance with current clinical guidelines. All patients in the study group received baseline prognosis-modifying conservative therapy for CAD. Evaluated parameters included anamnestic data, cardiovascular disease risk factors (arterial hypertension, diabetes mellitus, smoking, excess body weight), laboratory findings (complete blood count and biochemical blood analysis), and instrumental parameters (echocardiography, 24-hour electrocardiogram monitoring, coronary angiography). Cognitive status was assessed using the Mini-Mental State Examination (MMSE) questionnaire.</p><p>Assessment of induced blood oxidation (IBO) parameters was performed using a YSI 5300 biological oxygen monitor (Yellow Springs Instrument Co., Inc., USA). Free radical oxidation of blood components was induced by the water-soluble initiator AAPH (2,2'-azobis(2-amidinopropane) dihydrochloride). IBO parameters were evaluated upon admission (Time point 1 — B1), 10 days after surgery (Time point 2 — B2), and 6 months after surgery (Time point 3 — B3). It was experimentally established that the oxygen consumption process occurs non-linearly.</p><p>Based on the slope of the oxygen concentration curve in the sample, the following were determined:</p><p>Statistical data processing was performed using the STATISTICA 10.0 software package (StatSoft Inc., USA). The normality of the distribution of quantitative traits was checked using the Kolmogorov-Smirnov test with the Lilliefors correction. Homogeneity of qualitative traits was assessed based on contingency table analysis. Equality of population variances was tested using Fisher's and Cochran's tests.</p><p>Due to the non-normal distribution of the studied quantitative traits, medians and interquartile ranges were calculated. The interquartile range was indicated as the 25th and 75th percentiles. The presented data are expressed as Me (25.0%; 75.0%).</p><p>For comparing two independent groups by a single trait, the Mann-Whitney U test, χ² test, and Fisher's exact test were used. Dependent groups were compared using the Wilcoxon signed-rank test. For one-factor comparison of three or more independent groups, ANOVA (analysis of variances) by Kruskal-Wallis, the median test, and the χ² test were used. Nonparametric analysis of variance for three or more dependent groups was performed using Friedman's ANOVA.</p><p>To study the relationship between two traits, Spearman's rank correlation analysis was used. The nature of the dependence of a trait on one or more other traits was investigated using logistic regression analysis.</p><p>Results and discussion</p><p>In a comparative aspect, patients with CAD demonstrated higher (p &lt;0.05) values of induced blood oxidation parameters (Vox, Vinit, Vmax) and the oxidative activity coefficient (KA), and a shorter (p &lt;0.05) initiation period (T) (Table 1) compared to healthy volunteers. This indicates an intensification of free radical oxidation processes in this patient group.</p><p>Table 1. Comparative analysis of induced blood oxidation parameters in the group of patients with coronary artery disease compared to healthy individuals</p><p>ParameterControl Group (n=24)CAD (n=89)pBlood oxidation rate (Vox), 10-8 mol/L·s1.90 (1.7; 2.2)2.07 (1.8; 2.3)0.049Initiation period time (T), min1.91 (1.3; 2.5)0.97 (0.67; 1.34)0.001Initial oxidation rate (Vinit), 10-8 mol/L·s2.11 (1.6; 2.9)3.29 (2.5; 4.83)0.0001Maximum oxidation rate (Vmax), 10-8 mol/L·s2.54 (2.1; 3.1)3.5 (2.76; 4.83)0.001Oxidative activity coefficient (KA), %5.89 (-11.0; 22.7)40 (15.65; 55.5)0.0001</p><p>It was established that patients with CAD exhibit higher values of markers associated with increased ROS production, even in the absence of obstructive lesions [7, 8].</p><p>A total of 6 cases of fatal outcomes were recorded. No statistically significant differences in IBO parameters were found in the overall group (n=89) depending on fatal outcome. However, in the group of patients with a history of myocardial infarction (PMI) (n=64), the blood oxidation rate Vox in deceased patients was statistically significantly higher (2.3 (2.3; 2.5) vs. 1.9 (1.7; 2.3), respectively; p = 0.04).</p><p>Coronary artery bypass grafting using a cardiopulmonary bypass machine (on-pump) was performed in 31 patients, while off-pump surgery on the beating heart was performed in 33 patients. In a comparative aspect, no statistically significant differences were observed in IBO parameter values during the postoperative period between patients who underwent off-pump surgery and those who underwent surgery with cardiopulmonary bypass. In patients whose surgery was performed under CPB, an increase in time T and a decrease in Vmax values were observed after 6 months (p &lt;0.05). In the off-pump group, 10 days after surgery (B2), a decrease in time T and an increase in Vinit, Vmax, and KA were observed (p &lt;0.05). After 6 months (B3), these parameters were comparable to preoperative values (B1) (Table 2). Thus, it was concluded that changes in parameters characterizing oxidative status during revascularization are transient in nature and do not depend on the chosen method of coronary artery bypass grafting.</p><p>Table 2. Dynamics of induced blood oxidation parameters depending on the revascularization technique</p><p>ParameterOn-pump (n=31)  Off-pump (n=33)   B1B2B3B1B2B3T0.83 4 (0.63; 1.04)1.04 (0.67; 1.5)1.17 1 (0.9; 1.7)1.14 (0.79; 1.38)0.75 2 (0.57; 1.16)1.17 3 (0.99; 1.44)Vinit3.73 (3.07; 4.5)3.5 (2.3; 4.46)3.08 (2.16; 3.56)2.9 (2.3; 4.06)3.93 2 (2.8; 5.49)2.91 3 (2.41; 3.46)Vmax3.8 (3.1; 4.5)3.73 (2.63; 5.03)3.1 1 (2.3; 3.56)3.03 (2.68; 4.28)4.13 2 (3.03; 5.49)2.96 3 (2.6; 3.53)KA46.15 (21.8; 56.8)39.4 (17.2; 61.95)28.72 (9.24; 45.7)27.6 (9.26; 48.72)38.68 2 (32.14; 68.0)30.98 3 (20.23; 36.56)Notes: 1 ---- On-pump B1-B3 -- p &lt;0.05; 2 ---- Off-pump B1-B2 -- p &lt;0.05;3 ---- Off-pump B2-B3 -- p &lt;0.05; 4 ---- On-pump and Off-pump B1 comparison -- p &lt;0.05.</p><p>Inevitable consequences of coronary artery bypass grafting are the systemic inflammatory response and the closely related oxidative stress [<xref ref-type="bibr" rid="cit9">9</xref>], which are typically transient in nature [<xref ref-type="bibr" rid="cit10">10</xref>]. One of the mechanisms responsible for increased ROS production after revascularization is the ischemia-reperfusion phenomenon, where restoration of blood flow can even exacerbate myocardial damage [<xref ref-type="bibr" rid="cit11">11</xref>].</p><p>Cardiac arrhythmias (atrial fibrillation, ventricular and supraventricular extrasystole) were registered in the early postoperative period in 45 patients. The results of logistic regression analysis demonstrated a statistically significant (p=0.0001) effect of the blood oxidation rate (Vox) on the development of cardiac arrhythmias. A statistically significant (p=0.013) effect of the terminal blood oxidation rate (Vterm) on the development of supraventricular extrasystole was also registered during off-pump revascularization.</p><p>Atrial fibrillation (AF), being one of the most common cardiac arrhythmias in the population, is the most frequent early postoperative complication after coronary artery bypass grafting [<xref ref-type="bibr" rid="cit12">12</xref>]. It has been established that the intensification of ROS production after revascularization contributes additionally to arrhythmogenesis through cellular calcium overload, resulting from activation of the ryanodine receptor-2 (RYR-2) and mediated effects on fibroblast proliferation with subsequent structural remodeling of atrial tissue [13-15].</p><p>Cognitive status was assessed using the MMSE questionnaire. A total of 3 cases of postoperative cognitive dysfunction were registered, occurring exclusively in the group of patients with high Vox values (&gt;2.29×10-8 mol/L·s, p=0.035). The results of logistic regression analysis established a significant effect of Vox value on the development of postoperative cognitive dysfunction (p=0.004).</p><p>Oxidative stress, developing in the context of ischemia-reperfusion, exhibits a neurodegenerative effect by inhibiting mitochondrial respiration and thereby promoting the accumulation of free radicals in brain tissue, which is extremely sensitive to harmful effects due to weak endogenous antioxidant defense [16, 17].</p><p>Conclusion</p><p>Coronary artery disease is accompanied by significant changes in oxidative status, with a shift in balance towards activation of free radical oxidation processes. These processes intensify during myocardial revascularization, which in some cases contributes to the development of complications such as cardiac arrhythmias and cognitive dysfunction. Preoperative monitoring of parameters characterizing oxidative status allows for the identification of a risk group for the development of adverse events during the treatment of patients with CAD.</p></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chong B, Jayabaskaran J, Jauhari SM, et al. The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050. J Am Coll Cardiol. 2025 Jul 22;86(3):165-177. doi: 10.1016/j.jacc.2025.04.061.</mixed-citation><mixed-citation xml:lang="en">Chong B, Jayabaskaran J, Jauhari SM, et al. The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050. J Am Coll Cardiol. 2025 Jul 22;86(3):165-177. doi: 10.1016/j.jacc.2025.04.061.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Самородская И.В., Чернявская Т.К Т.К., Какорина Е.П., Семенов В.Ю. Ишемические болезни сердца: анализ медицинских свидетельств о смерти. Российский кардиологический журнал. 2022;27(1):4637. https://doi.org/10.15829/1560-4071-2022-4637</mixed-citation><mixed-citation xml:lang="en">Samorodskaya I.V., Chernyavskaya T.K., Kakorina E.P., Semyonov V.Yu. Ischemic heart disease: medical certificate of cause of death analysis. Russian Journal of Cardiology. 2022;27(1):4637. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Poznyak AV, Grechko AV, Orekhova VA, et al. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060.</mixed-citation><mixed-citation xml:lang="en">Poznyak AV, Grechko AV, Orekhova VA, et al. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Papadakis E, Kanakis M, Kataki A, Spandidos DA. The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review). Mol Med Rep. 2018 Feb;17(2):2089-2099. doi: 10.3892/mmr.2017.8174.</mixed-citation><mixed-citation xml:lang="en">Papadakis E, Kanakis M, Kataki A, Spandidos DA. The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review). Mol Med Rep. 2018 Feb;17(2):2089-2099. doi: 10.3892/mmr.2017.8174.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vukicevic P, Klisic A, Neskovic V, et al. Oxidative Stress in Patients before and after On-Pump and Off-Pump Coronary Artery Bypass Grafting: Relationship with Syntax Score. Oxid Med Cell Longev. 2021 Jul 30;2021:3315951. doi: 10.1155/2021/3315951.</mixed-citation><mixed-citation xml:lang="en">Vukicevic P, Klisic A, Neskovic V, et al. Oxidative Stress in Patients before and after On-Pump and Off-Pump Coronary Artery Bypass Grafting: Relationship with Syntax Score. Oxid Med Cell Longev. 2021 Jul 30;2021:3315951. doi: 10.1155/2021/3315951.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ghezzi P. Environmental risk factors and their footprints in vivo - A proposal for the classification of oxidative stress biomarkers. Redox Biol. 2020 Jul;34:101442. doi: 10.1016/j.redox.2020.101442.</mixed-citation><mixed-citation xml:lang="en">Ghezzi P. Environmental risk factors and their footprints in vivo - A proposal for the classification of oxidative stress biomarkers. Redox Biol. 2020 Jul;34:101442. doi: 10.1016/j.redox.2020.101442.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Varadhan S, Venkatachalam R, Perumal SM, Ayyamkulamkara SS. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients. Arch Razi Inst. 2022 Apr 30;77(2):853-859. doi: 10.22092/ARI.2022.357069.1965.</mixed-citation><mixed-citation xml:lang="en">Varadhan S, Venkatachalam R, Perumal SM, Ayyamkulamkara SS. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients. Arch Razi Inst. 2022 Apr 30;77(2):853-859. doi: 10.22092/ARI.2022.357069.1965.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen D, Liang M, Jin C, et al. Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score. Exp Ther Med. 2020 Sep;20(3):2127-2133. doi: 10.3892/etm.2020.8958.</mixed-citation><mixed-citation xml:lang="en">Chen D, Liang M, Jin C, et al. Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score. Exp Ther Med. 2020 Sep;20(3):2127-2133. doi: 10.3892/etm.2020.8958.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Alam SR, Stirrat C, Spath N, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6.</mixed-citation><mixed-citation xml:lang="en">Alam SR, Stirrat C, Spath N, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto M, Nishimori H, Fukutomi T, et al. Dynamics of Oxidative Stress Evoked by Myocardial Ischemia Reperfusion After Off-Pump Coronary Artery Bypass Grafting Elucidated by Bilirubin Oxidation. Circ J. 2017 Oct 25;81(11):1678-1685. doi: 10.1253/circj.CJ-16-1116.</mixed-citation><mixed-citation xml:lang="en">Yamamoto M, Nishimori H, Fukutomi T, et al. Dynamics of Oxidative Stress Evoked by Myocardial Ischemia Reperfusion After Off-Pump Coronary Artery Bypass Grafting Elucidated by Bilirubin Oxidation. Circ J. 2017 Oct 25;81(11):1678-1685. doi: 10.1253/circj.CJ-16-1116.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou M, Yu Y, Luo X, et al. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective. Cardiology. 2021;146(6):781-792. doi: 10.1159/000518879.</mixed-citation><mixed-citation xml:lang="en">Zhou M, Yu Y, Luo X, et al. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective. Cardiology. 2021;146(6):781-792. doi: 10.1159/000518879.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018 Mar;63(1):30-35. doi: 10.1016/j.advms.2017.06.005.</mixed-citation><mixed-citation xml:lang="en">Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018 Mar;63(1):30-35. doi: 10.1016/j.advms.2017.06.005.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zakkar M, Ascione R, James AF, et al. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015 Oct;154:13-20. doi: 10.1016/j.pharmthera.2015.06.009.</mixed-citation><mixed-citation xml:lang="en">Zakkar M, Ascione R, James AF, et al. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015 Oct;154:13-20. doi: 10.1016/j.pharmthera.2015.06.009.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mustroph J, Neef S, Maier LS. CaMKII as a target for arrhythmia suppression. Pharmacol Ther. 2017 Aug;176:22-31. doi: 10.1016/j.pharmthera.2016.10.006.</mixed-citation><mixed-citation xml:lang="en">Mustroph J, Neef S, Maier LS. CaMKII as a target for arrhythmia suppression. Pharmacol Ther. 2017 Aug;176:22-31. doi: 10.1016/j.pharmthera.2016.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ren X, Wang X, Yuan M, et al. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation. Curr Pharm Des. 2018;24(26):3062-3071. doi: 10.2 174/1381612824666180903144042.</mixed-citation><mixed-citation xml:lang="en">Ren X, Wang X, Yuan M, et al. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation. Curr Pharm Des. 2018;24(26):3062-3071. doi: 10.2 174/1381612824666180903144042.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Полушин Ю.С., Полушин А.Ю., Юкина Г.Ю., Кожемякина М.В. Послеоперационная когнитивная дисфункция – что мы знаем и куда двигаться далее. Вестник анестезиологии и реаниматологии. 2019;16(1):19-28. https://doi.org/10.21292/2078-5658-2019-16-1-19-28</mixed-citation><mixed-citation xml:lang="en">Polushin Yu.S., Polushin A. Yu., Yukina G.Yu., Kozhemyakina M.V. Postoperative cognitive dysfunction – what we know and where we go. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2019;16(1):19-28. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018 May;15:490-503. doi: 10.1016/j.redox. 2018.01.008.</mixed-citation><mixed-citation xml:lang="en">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018 May;15:490-503. doi: 10.1016/j.redox. 2018.01.008.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
